Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells.

Inhibition of ubiquitin ligases with small molecule remains a very challenging task, given the lack of catalytic activity of the target and the requirement of disruption of its interactions with other proteins. Siah1/2, which are E3 ubiquitin ligases, are implicated in melanoma and prostate cancer and represent high-value drug targets. ...
We utilized three independent screening approaches in our efforts to identify small-molecule Siah1/2 inhibitors: Affinity Selection-Mass Spectrometry, a protein thermal shift-based assay and an in silico based screen. Inhibitors were assessed for their effect on viability of melanoma and prostate cancer cultures, colony formation, prolyl-hydroxylase-HIF1? signaling, expression of selected Siah2-related transcripts, and Siah2 ubiquitin ligase activity. Several analogs were further characterized, demonstrating improved efficacy. Combination of the top hits identified in the different assays demonstrated an additive effect, pointing to complementing mechanisms that underlie each of these Siah1/2 inhibitors.
Mesh Terms:
Animals, Cell Line, Tumor, Cell Proliferation, Cell Survival, Computer Simulation, Down-Regulation, Drug Screening Assays, Antitumor, Gene Expression Regulation, Neoplastic, Humans, Male, Mass Spectrometry, Melanoma, Mice, Nuclear Proteins, Prostatic Neoplasms, Small Molecule Libraries, Ubiquitin-Protein Ligases, Xenograft Model Antitumor Assays
Cancer Lett.
Date: Dec. 01, 2018
Download Curated Data For This Publication
221153
Switch View:
  • Interactions 1